Sugiyama S
Department of Biomedical Chemistry, Institute of Applied Biochemistry, Gifu, Japan.
Biochem Mol Biol Int. 1998 Dec;46(5):923-31. doi: 10.1080/15216549800204472.
We examined effects of pravastatin on age-related changes in mitochondrial function in rats. Decline in the activity of complex I of the mitochondrial electron transport chain was observed in diaphragm and psoai major in rats aged 35 and 55 weeks, and that of complex IV in rats aged 55 weeks. Pravastatin accelerated significantly age-related decline in the activity of complex I of diaphragm mitochondria, though pravastatin did not show significant effect on normally observed age-associated decline in the activities of complex IV of psoai major and diaphragm mitochondria. Aging effect on mitochondrial respiratory function was not observed on heart muscle and liver in rats up to 55 weeks old, and pravastatin did not effect significantly heart and liver mitochondrial respiratory function. From these results, careful clinical examination on respiratory muscle function should be necessary in patients treated with pravastatin particularly in elderly patients.
我们研究了普伐他汀对大鼠线粒体功能与年龄相关变化的影响。在35周龄和55周龄大鼠的膈肌和腰大肌中观察到线粒体电子传递链复合体I活性下降,在55周龄大鼠中观察到复合体IV活性下降。普伐他汀显著加速了膈肌线粒体复合体I活性与年龄相关的下降,尽管普伐他汀对正常观察到的腰大肌和膈肌线粒体复合体IV活性与年龄相关的下降没有显著影响。在55周龄以下的大鼠中,未观察到衰老对心肌和肝脏线粒体呼吸功能的影响,普伐他汀对心脏和肝脏线粒体呼吸功能也没有显著影响。从这些结果来看,在用普伐他汀治疗的患者中,尤其是老年患者,应对呼吸肌功能进行仔细的临床检查。